Novo Nordisk hikes full-year forecast on GLP-1 drug sales, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Novo Nordisk was overwhelmed by demand for Wegovy after it was launched in the United States in 2021 and the firm’s supply constraints were exacerbated when a contract manufacturer had to temporarily suspend production over manufacturing issues., Novo Nordisk was overwhelmed by demand for Wegovy after it was launched in the United States in 2021 and the firm’s supply constraints were exacerbated when a contract manufacturer had to temporarily suspend production over manufacturing issues., , Read More